This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
50 mg/5mL, Injection, powder, lyophilized, for solution
INN: TIGECYCLINE
Data updated: 2026-04-26
Available in:
🇨🇿🇬🇧🇵🇹🇸🇰
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Dosage
50 mg/5mL
Route
INTRAVENOUS
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
ATC Code
J01AA12
Source
OPENFDA_NDC
(
ARTG
)
TYGACIL is indicated for the treatment of the following infections in adults: - Complicated skin and skin structure infections, including those with methicillin-resistant Staphylococcus aureus (MRSA), where there is suspected or proven resistance to, or intolerance of, or there are co-morbidities preventing its use of, other available agents. Complicated intra-abdominal infections, where there is suspected or proven resistance to, or intolerance of, or there are co-morbidities preventing its use of, other available agents.
⚠️ Warnings
• Caution should be exercised in patients with liver disease, inflammation of pancreas, severe allergic reactions, who are taking other medications, any allergy, during pregnancy and breastfeeding.
• It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.
• Avoid exposure to sunlight; otherwise it may cause sunburn easily.
• Avoid long-term use of this medication; otherwise it may cause secondary infection.
• It should not be used in children.